Abnormalities in insulin secretion in type 2 diabetes mellitus (Q37221760)

19 August 2017

1 reference

title

Abnormalities in insulin secretion in type 2 diabetes mellitus (English)

1 reference

19 August 2017

0 references

1 reference

P-J Guillausseau

1

1 reference

19 August 2017

T Meas

2

1 reference

19 August 2017

M Virally

3

1 reference

19 August 2017

M Laloi-Michelin

4

1 reference

19 August 2017

V Médeau

5

1 reference

19 August 2017

J-P Kevorkian

6

1 reference

19 August 2017

1 February 2008

1 reference

19 August 2017

Diabetes and Metabolism

1 reference

19 August 2017

34 Suppl 2

1 reference

19 August 2017

S43-8

1 reference

Immunoassay of endogenous plasma insulin in man

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Pathophysiology of impaired pulsatile insulin release

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Calcium-mediated cell injury and cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Paradoxical Inhibition of Insulin Secretion by Glucose in Human Diabetes Mellitus*

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Insulin secretion in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Quantitative and qualitative changes in the early insulin response to glucose in subjects with impaired carbohydrate tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Decreased Sensitivity of the Pancreatic Beta Cells to Glucose in Prediabetic and Diabetic Subjects: A Glucose Dose-Response Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Analysis of early-phase insulin responses in nonobese subjects with mild glucose intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Loss of the first phase insulin response to intravenous glucose in subjects with persistent impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Relationships Between Fasting Plasma Glucose Levels and Insulin Secretion During Intravenous Glucose Tolerance Tests

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

The contribution of proinsulin and des-31,32 proinsulin to the hyperinsulinemia of diabetic and nondiabetic cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

1 reference

7 January 2021

Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Islet amyloid and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Uncoupling protein 2 and islet function

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Evidence for a circulating islet cell growth factor in insulin-resistant states

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

TCF7L2: the biggest story in diabetes genetics since HLA?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Fetal and infant growth and impaired glucose tolerance at age 64.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

In utero undernutrition impairs rat beta-cell development

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Effect of ageing on beta-cell mass and function in rats malnourished during the perinatal period

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Thinness at birth and insulin resistance in adult life.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Endocrine pancreas development in growth-retarded human fetuses

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

No evidence for a major beta-cell dysfunction in young adults born with intra-uterine growth retardation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Fetal growth and the physiological control of glucose tolerance in adults: a minimal model analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973394-9

7 January 2021

10.1016/S1262-3636(08)73394-9

Identifiers

DOI

1 reference

19 August 2017

1 reference